Stay updated on MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record describes a completed Phase IIb trial evaluating MEDI0382 (cotadutide) for overweight or obese adults with type 2 diabetes, comparing several doses with placebo and liraglutide. It also provides participant eligibility details, study locations, outcome measures, and study documents.
    Difference
    100%
    Check dated 2026-11-07T14:20:42.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T15:13:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:10:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T19:31:59.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T19:52:48.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content. This change removes access to the study’s details and related information presented on the page.
    Difference
    17%
    Check dated 2026-09-19T20:53:48.000Z thumbnail image

Stay in the know with updates to MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI0382 Efficacy & Safety in Type 2 Diabetes Clinical Trial page.